Mia's Feed
Medical News & Research

New Dendritic Nanotubular Network Discovered in the Brain and Its Potential Role in Alzheimer's Disease

New Dendritic Nanotubular Network Discovered in the Brain and Its Potential Role in Alzheimer's Disease

Share this article

Scientists have identified new dendritic nanotubes in the brain that may contribute to the spread of Alzheimer's disease by transporting amyloid-beta proteins, opening new pathways for early intervention.

2 min read

Researchers have uncovered a novel type of nanotube structure within the brain's neural tissue, termed dendritic nanotubes (DNTs), which may play a significant role in the development of Alzheimer's disease. Historically, neurons communicate via synapses, but recent findings suggest that cells also utilize nanotube structures for intercellular material exchange. While tunneling nanotubes (TNTs) are known to facilitate the transfer of substances between cells, their presence and function in mature brain neurons have remained ambiguous.

In this groundbreaking study, scientists employed superresolution microscopy and electron microscopy to identify DNTs connecting dendrites in both mouse and human brain tissues. These actin-rich nanotubes were observed forming dynamically between dendrites in the cortex, distinguishing themselves from other neuronal structures through advanced machine-learning analysis that confirmed their unique shape and internal organization.

Unlike TNTs, DNTs do not form open tunnels. Instead, their ends are closed, yet they are capable of transporting various materials, including calcium ions and small molecules. To explore their potential role in neurodegenerative processes, the team introduced amyloid-beta peptides—linked to Alzheimer's pathology—into neurons within mouse brain slices. They discovered that DNTs facilitated the spread of amyloid-beta between neurons, a process that could be suppressed by inhibiting nanotube formation.

Further computational modeling revealed that the density of DNTs increases prior to the formation of amyloid plaques, a hallmark of Alzheimer's disease, indicating a possible early involvement in disease progression. The models suggested that overactivation of these nanotubes could accelerate amyloid accumulation, providing a mechanistic insight into how cellular connectivity might influence neurodegeneration.

Despite these promising findings, much remains to be understood about DNTs, including their full range of functions in healthy and diseased brains. Future research could unveil additional roles for these structures, potentially opening new avenues for early detection and intervention in Alzheimer’s disease, based on their involvement in the spread of pathogenic proteins.

This discovery enhances our understanding of cellular communication in the brain and presents potential targets for therapeutic strategies aimed at halting or slowing the progression of Alzheimer's disease.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Australian School-Based Program Significantly Cuts Teen Vaping Rates by 65%

A pioneering school-based vaping prevention program in Australia has reduced teenage vaping by 65%, emphasizing the importance of interactive education in youth health initiatives.

Using ChatGPT to Determine Eligibility for Clinical Trials

AI technologies like ChatGPT are revolutionizing clinical trial screening by quickly analyzing patient data to identify eligible candidates, reducing delays and improving trial efficiency.

High Midlife Stress Hormone Levels May Increase Alzheimer's Risk in Postmenopausal Women

Research links elevated stress hormone levels in midlife to increased Alzheimer's risk in postmenopausal women, emphasizing early detection and preventive strategies.

Telemedicine and Innovative Scoring Enhance Safety in Post-Stroke Hypertension Management

Innovative tools like the TRICH score and telemedicine are transforming post-stroke hypertension management, reducing recurrence risks and improving patient outcomes.